Clinical Trials Directory

Trials / Sponsors / Atrial Fibrillation Network

Atrial Fibrillation Network

Academic / Other · 14 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingCatheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Va
Atrial Fibrillation (AF), Mitral Valve (MV) Regurgitation
N/A2026-07-01
RecruitingEarly Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AF
Atrial Fibrillation
N/A2024-10-14
UnknownClinical Cohorts for Validation of New Digital Biomarkers
Atrial Fibrillation
2023-03-02
CompletedThe Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNE
Atrial Arrhythmia
N/A2021-01-26
CompletedCompare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Dise
Atrial Fibrillation, End-stage Kidney Disease
Phase 32017-06-20
TerminatedNon-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Atrial High Rate Episodes
Phase 32016-02-01
CompletedApixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Atrial Fibrillation
Phase 42014-12-01
CompletedEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial
Atrial Fibrillation, Stroke
Phase 42011-07-01
WithdrawnKONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation
Atrial Fibrillation
N/A2006-09-01
CompletedRandomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation
Atrial Fibrillation
N/A2006-02-01
CompletedFlecainide-Short Long Study (Flec-SL)
Atrial Fibrillation
N/A2005-03-01
CompletedTrial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Heart Disease, Arrhythmia, Atrial Fibrillation
Phase 32005-01-01
CompletedRecurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy
Atrial Fibrillation
2005-01-01
CompletedProspective Registration and Assessment of Serious Adverse Events Within the AFNET
Atrial Fibrillation, Assessment of Serious Advers Events, Thromboembolic and Bleeding Complications
2004-02-01